Alpha 2.0
Login Register
» Authors » C Wittekind

C Wittekind

Explore the profile of C Wittekind including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 256
Citations 2723
Followers 0
Related Specialties
General Surgery
Pathology
Oncology
Top 10 Co-Authors
A Tannapfel
P Hermanek
F Kockerling
J Hauss
W Hohenberger
S von Kleist
A Katalinic
B Ringe
R Pichlmayr
J Mossner
Published In
Pathologe
Zentralbl Chir
Dtsch Med Wochenschr
Z Gastroenterol
Verh Dtsch Ges Pathol
Affiliations
Soon will be listed here.
Recent Articles
1.
Mismatch repair deficiency, chemotherapy and survival for resectable gastric cancer: an observational study from the German staR cohort and a meta-analysis
Stolze T, Franke S, Haybaeck J, Moehler M, Grimminger P, Lang H, et al.
J Cancer Res Clin Oncol . 2022 Feb; 149(3):1007-1017. PMID: 35211781
Purpose: In a post hoc analysis of the MAGIC trial, patients with curatively resected gastric cancer (GC) and mismatch repair (MMR) deficiency (MMRd) had better median overall survival (OS) when...
2.
Bitzer M, Voesch S, Albert J, Bartenstein P, Bechstein W, Blodt S, et al.
Z Gastroenterol . 2022 Feb; 60(2):219-238. PMID: 35148562
No abstract available.
3.
Bitzer M, Voesch S, Albert J, Bartenstein P, Bechstein W, Blodt S, et al.
Z Gastroenterol . 2022 Feb; 60(2):e186-e227. PMID: 35148560
No abstract available.
4.
[Pretherapeutic misclassification of esophageal cancer and adenocarcinoma of the esophagogastric junction : Possibilities and clinical consequences]
Gockel I, Lordick F, Lyros O, Kreuser N, Holscher A, Wittekind C
Chirurg . 2019 Aug; 91(1):41-50. PMID: 31372677
During the course of a malignant disease, the tumor needs to be classified repeatedly in order to facilitate decision-making in treatment and to estimate patients prognosis; however, a wrong classification...
5.
[Gottfried Geiler : December 13, 1927-April 28, 2018]
Wittekind C
Pathologe . 2018 Sep; 39(Suppl 2):348-349. PMID: 30206652
No abstract available.
6.
Neoadjuvant rectal score as individual-level surrogate for disease-free survival in rectal cancer in the CAO/ARO/AIO-04 randomized phase III trial
Fokas E, Fietkau R, Hartmann A, Hohenberger W, Grutzmann R, Ghadimi M, et al.
Ann Oncol . 2018 May; 29(7):1521-1527. PMID: 29718095
Background: Surrogate end points in rectal cancer after preoperative chemoradiation are lacking as their statistical validation poses major challenges, including confirmation based on large phase III trials. We examined the...
7.
Proposal for an extended pTNM classification of thyroid carcinoma : Commentary on deficits of the 8th edition of the TNM classification
Schmid K, Synoracki S, Dralle H, Wittekind C
Pathologe . 2018 Feb; 40(Suppl 1):18-24. PMID: 29459993
In the 8th edition of the TNM classification of thyroid carcinomas, which was introduced in 2017, carcinomas with minimal extrathyroidal extension are no longer mentioned, which might cause problems. These...
8.
[Proposal for an extended pTNM classification of thyroid carcinoma : Commentary on deficits of the 8th edition of the TNM classification (German version)]
Schmid K, Synoracki S, Dralle H, Wittekind C
Pathologe . 2018 Jan; 39(1):49-56. PMID: 29372307
In the 8th edition of the TNM classification of thyroid carcinomas, which was introduced in 2017, carcinomas with minimal extrathyroidal extension are no longer mentioned, which might cause problems. These...
9.
[Requirements of clinicians on pathology : A viewpoint from pathology]
Wittekind C, Burrig K
Pathologe . 2017 Aug; 38(5):394-395. PMID: 28808773
No abstract available.
10.
[R1 resection of esophageal carcinoma]
Gockel I, Wittekind C
Chirurg . 2017 Aug; 88(9):748-755. PMID: 28770271
The microscopic identification of residual tumor tissue in the oral or aboral resection margins (R1 resection) of esophageal specimens following oncologic esophageal resection, increases the risk of tumor recurrence and...